BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6303060)

  • 1. The use of cefotaxime in pneumology.
    Grassi C; Colombo ML; Peona V
    Acta Med Port; 1983 Feb; 4(2):87-90. PubMed ID: 6303060
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM; Veldkamp J; Deleers L
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience in the treatment of bacterial bronchopneumopathy with cefotaxime].
    Montanari S; Roca A; Pasqua F; Gramiccioni E
    Clin Ter; 1983 Apr; 105(2):119-24. PubMed ID: 6305552
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic efficacy and tolerability of cefotaxime--a study of acute respiratory infections in chronic lung conditions.
    Shah SP; Mehta AP; Shetty SR; Mahashur AA; Kamat SR
    J Postgrad Med; 1988 Jan; 34(1):15-20. PubMed ID: 3385652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ambulatory anti-infective therapy. Multicentric studies with cefotaxime treatment of 12,181 patients].
    Pozzi E; Luisetti M; Peona V; Colombo ML
    G Ital Chemioter; 1982; 29(1):21-38. PubMed ID: 6309598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison between cefoperazone and cefotaxime in the treatment of infections of the lower respiratory tract].
    Fantoni U; Ruffilli MP; Ecari U
    Clin Ter; 1987 May; 121(3):209-12. PubMed ID: 2956011
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of cefotiam in the treatment of bacterial infections].
    Mussini C; Zanni G; Braglia MP
    Clin Ter; 1984 Dec; 111(5):401-9. PubMed ID: 6097395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with a ampicillin-dicloxacillin combination in pneumology].
    Loianno R
    Clin Ter; 1977 Jul; 82(2):127-37. PubMed ID: 902467
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ceftizoxime in the treatment of urinary tract and respiratory infections in liver disease patients].
    Esposito S; Galante D; Barba D
    G Ital Chemioter; 1985; 32(2):361-5. PubMed ID: 3869114
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use in pneumology of a new antibiotic: kanendomycin].
    Giura R; Rossini G
    G Ital Chemioter; 1977; 24(1-2):11-4. PubMed ID: 615752
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ceftizoxime in the treatment of infective pathology in the elderly].
    Garotta F; Magni O; Meinardi G
    Boll Chim Farm; 1986 Dec; 125(12):127S-131S. PubMed ID: 3473994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aerosol therapy in pneumological practice, with the exception of tuberculosis].
    Unteanu G; Basacopol A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):375-8. PubMed ID: 6304855
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
    Kaneko H; Masaki T; Yamaguchi R; Takahashi N; Umeda M; Shirai T
    Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime in the management of acute lower respiratory tract infection.
    Keelan P; Hone R; Martin L; Callaghan B; Harty M
    Ir Med J; 1982 May; 75(5 Suppl):6-7. PubMed ID: 6284676
    [No Abstract]   [Full Text] [Related]  

  • 17. [Respiratory infections in chronic bronchopneumopathies: treatment with ceftizoxime].
    Foddai GA; Pisano PL; Cardia P; Mereu S; Ligia GP; Farris A; Falqui AM; Pau LA
    G Ital Chemioter; 1984; 31(3):238-41. PubMed ID: 6100179
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the effectiveness of ceftizoxime in the treatment of respiratory tract infections].
    Gialdroni Grassi G; Manara G; Mangiarotti P; Navone A
    G Ital Chemioter; 1982; 29(1):49-54. PubMed ID: 6309599
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.
    Lode H; Glatzel PD
    Infection; 1985; 13 Suppl 1():S25-7. PubMed ID: 4055050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.